Altimmune (ALT)
(Delayed Data from NSDQ)
$6.24 USD
+0.14 (2.30%)
Updated Oct 8, 2024 04:00 PM ET
After-Market: $6.25 +0.01 (0.16%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Altimmune, Inc. (ALT) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$20.57 | $28.00 | $10.00 | 237.21% |
Price Target
Based on short-term price targets offered by seven analysts, the average price target for Altimmune, Inc. comes to $20.57. The forecasts range from a low of $10.00 to a high of $28.00. The average price target represents an increase of 237.21% from the last closing price of $6.10.
Analyst Price Targets (7 )
Broker Rating
Altimmune, Inc. currently has an average brokerage recommendation (ABR) of 1.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 1.50 a month ago based on eight recommendations.
Of the eight recommendations deriving the current ABR, six are Strong Buy, representing 75% of all recommendations. A month ago, Strong Buy represented 75%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 6 | 6 | 5 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.50 | 1.50 | 1.50 | 1.50 | 1.57 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/22/2024 | H.C. Wainwright & Co. | Patrick Trucchio | Strong Buy | Strong Buy |
8/9/2024 | Evercore Partners | Liisa A Bayko | Not Available | Strong Buy |
8/2/2024 | B. Riley Securities | Mayank Mamtani | Strong Buy | Strong Buy |
6/20/2024 | Piper Sandler | Yasmeen Rahimi | Strong Buy | Strong Buy |
5/6/2024 | Goldman Sachs | Corinne Johnson | Hold | Hold |
4/29/2024 | Guggenheim Securities | Seamus Fernandez | Strong Buy | Hold |
3/27/2024 | JMP Securities | Jonathan Wolleben | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.50 |
ABR (Last week) | 1.50 |
# of Recs in ABR | 8 |
Average Target Price | $20.57 |
LT Growth Rate | NA |
Industry | Medical - Drugs |
Industry Rank by ABR | 88 of 252 |
Current Quarter EPS Est: | -0.36 |
ALT FAQs
Altimmune, Inc. (ALT) currently has an average brokerage recommendation (ABR) of 1.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 8 brokerage firms.
The average price target for Altimmune, Inc. (ALT) is $20.57. The current on short-term price targets is based on 3 reports.
The forecasts for Altimmune, Inc. (ALT) range from a low of $10 to a high of $28. The average price target represents a increase of $237.21 from the last closing price of $6.10.
The current UPSIDE for Altimmune, Inc. (ALT) is 237.21%
Based on short-term price targets offered by seven analysts, the average price target for Altimmune, Inc. comes to $20.57. The forecasts range from a low of $10.00 to a high of $28.00. The average price target represents an increase of 237.21% from the last closing price of $6.10.